NO152839C - Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyrilderivater. - Google Patents
Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyrilderivater.Info
- Publication number
- NO152839C NO152839C NO790521A NO790521A NO152839C NO 152839 C NO152839 C NO 152839C NO 790521 A NO790521 A NO 790521A NO 790521 A NO790521 A NO 790521A NO 152839 C NO152839 C NO 152839C
- Authority
- NO
- Norway
- Prior art keywords
- carbostyric
- derivatives
- preparation
- therapeutic active
- analogy procedure
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/34—Oxygen atoms in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/24—Oxygen atoms attached in position 8
- C07D215/26—Alcohols; Ethers thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/36—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cardiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19782806721 DE2806721A1 (de) | 1978-02-17 | 1978-02-17 | Neue carbostyril-derivate |
DE19782853314 DE2853314A1 (de) | 1978-12-09 | 1978-12-09 | Neue carbostyril- und oxindolderivate, ihre herstellung und ihre verwendung als arzneimittel |
Publications (3)
Publication Number | Publication Date |
---|---|
NO790521L NO790521L (no) | 1979-08-20 |
NO152839B NO152839B (no) | 1985-08-19 |
NO152839C true NO152839C (no) | 1985-11-27 |
Family
ID=25773852
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO790521A NO152839C (no) | 1978-02-17 | 1979-02-16 | Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyrilderivater. |
Country Status (24)
Country | Link |
---|---|
EP (1) | EP0003771B1 (no) |
JP (1) | JPS54132581A (no) |
AT (1) | AT374183B (no) |
AU (1) | AU523147B2 (no) |
CA (1) | CA1116600A (no) |
CS (1) | CS227005B2 (no) |
DD (1) | DD141829A5 (no) |
DE (1) | DE2963868D1 (no) |
DK (1) | DK157017C (no) |
ES (3) | ES477517A1 (no) |
FI (1) | FI69064C (no) |
GR (1) | GR66565B (no) |
HK (1) | HK50485A (no) |
HU (1) | HU177522B (no) |
IE (1) | IE48179B1 (no) |
IL (1) | IL56677A (no) |
NO (1) | NO152839C (no) |
NZ (1) | NZ189685A (no) |
PH (1) | PH16698A (no) |
PL (3) | PL117771B1 (no) |
PT (1) | PT69244A (no) |
RO (2) | RO82013A (no) |
SU (2) | SU843739A3 (no) |
YU (1) | YU41146B (no) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1171624B (it) * | 1980-11-12 | 1987-06-10 | Thomae Gmbh Dr K | Indolinoni dotati di proprieta' farmaceutiche e procedimento per la loro produzione |
US4442111A (en) * | 1981-07-25 | 1984-04-10 | Dr. Karl Thomae Gesellschaft Mit Beschrankter Haftung | Antithrombotic sulfimino and sulfoximino indolinones-2 |
DE3217012A1 (de) * | 1982-05-06 | 1983-11-10 | Dr. Karl Thomae Gmbh, 7950 Biberach | Benzoxazin-2-one, deren herstellung und diese verbindungen enthaltende arzneimittel |
CA2093633A1 (en) * | 1991-08-23 | 1993-02-24 | Seiji Sato | Carbostyril derivative and platelets aggregation inhibitory agent |
US7186745B2 (en) | 2001-03-06 | 2007-03-06 | Astrazeneca Ab | Indolone derivatives having vascular damaging activity |
MY129350A (en) | 2001-04-25 | 2007-03-30 | Bristol Myers Squibb Co | Aripiprazole oral solution |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5082218A (no) * | 1973-11-10 | 1975-07-03 | ||
US3904761A (en) * | 1974-01-25 | 1975-09-09 | Hoechst Co American | Method of preventing thrombosis |
US4070470A (en) * | 1974-06-24 | 1978-01-24 | Otsuka Pharmaceutical Co., Ltd. | Platelet aggregation inhibiting carbostyrils, their compositions and method of use |
JPS5321176A (en) * | 1976-08-09 | 1978-02-27 | Otsuka Pharmaceut Co Ltd | Carbostyryl derivatives |
IE46852B1 (en) * | 1977-06-10 | 1983-10-05 | Otsuka Pharma Co Ltd | Novel carbostyril derivatives |
-
1979
- 1979-01-31 SU SU792716799A patent/SU843739A3/ru active
- 1979-02-07 DE DE7979100348T patent/DE2963868D1/de not_active Expired
- 1979-02-07 ES ES477517A patent/ES477517A1/es not_active Expired
- 1979-02-07 EP EP79100348A patent/EP0003771B1/de not_active Expired
- 1979-02-08 AT AT0093379A patent/AT374183B/de active
- 1979-02-12 GR GR58339A patent/GR66565B/el unknown
- 1979-02-13 DD DD79211007A patent/DD141829A5/de unknown
- 1979-02-14 RO RO79103556A patent/RO82013A/ro unknown
- 1979-02-14 RO RO7996613A patent/RO76683A/ro unknown
- 1979-02-15 FI FI790507A patent/FI69064C/fi not_active IP Right Cessation
- 1979-02-15 IL IL56677A patent/IL56677A/xx unknown
- 1979-02-15 YU YU366/79A patent/YU41146B/xx unknown
- 1979-02-16 HU HU79TO1094A patent/HU177522B/hu unknown
- 1979-02-16 IE IE313/79A patent/IE48179B1/en unknown
- 1979-02-16 NO NO790521A patent/NO152839C/no unknown
- 1979-02-16 PL PL1979213471A patent/PL117771B1/pl unknown
- 1979-02-16 PL PL1979222632A patent/PL119177B1/pl unknown
- 1979-02-16 PT PT69244A patent/PT69244A/pt unknown
- 1979-02-16 JP JP1716179A patent/JPS54132581A/ja active Granted
- 1979-02-16 NZ NZ189685A patent/NZ189685A/en unknown
- 1979-02-16 AU AU44329/79A patent/AU523147B2/en not_active Ceased
- 1979-02-16 DK DK069679A patent/DK157017C/da not_active IP Right Cessation
- 1979-02-16 PL PL1979222631A patent/PL119423B1/pl unknown
- 1979-02-19 CA CA000321738A patent/CA1116600A/en not_active Expired
- 1979-02-19 CS CS791091A patent/CS227005B2/cs unknown
- 1979-10-01 ES ES484634A patent/ES484634A1/es not_active Expired
- 1979-10-01 ES ES484633A patent/ES484633A1/es not_active Expired
- 1979-10-24 SU SU792835387A patent/SU852170A3/ru active
-
1980
- 1980-08-01 PH PH24380A patent/PH16698A/en unknown
-
1985
- 1985-07-04 HK HK504/85A patent/HK50485A/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO151321C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyrilderivater | |
NO151463C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive kinazolinderivater | |
NO152899C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive glycerolderivater. | |
NO152215C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 4,5-diaryl-2-nitroimidazoler | |
NO158099C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyrilderivater. | |
NO153177C (no) | Analogifremgangsmaate for fremstilling av farmakologisk aktive tetrazolylalkoksy-karbostyrilderivater. | |
NO149102C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive trans-4-fenyl-1,2,3,4-tetrahydro-1-naftalenamin-derivater | |
NO147243C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive ftalanderivater | |
NO156864B (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive piperinderivater. | |
NO151411C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-aryloksy-2-hydroksy-3-alkylenaminopropan-derivater | |
NO153569C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive merkaptoacetyl-prolin-derivater. | |
NO152129C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive omega-cyan-1, omega-difenyl-azaalkanderivater | |
NO156787C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater. | |
NO152414C (no) | Analogifremgangsmaate for fremstilling av terapeutisk virksomme 2,6-dialkoksybenzamider | |
NO151239C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-fenyliminoimidazolidiner | |
NO160079C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive cefem-derivater. | |
NO154054C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive hydroksypyrimidinderivater. | |
NO158739C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-piperazinopyrimidinderivater. | |
NO151285C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive di-o-n-alkyl-glycerolderivater | |
NO151660C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive imidazolderivater. | |
NO160512C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyrilderivater. | |
NO154052C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolon-derivater. | |
NO146863C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive alkyltiofenoksyalkylaminer | |
NO152839C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyrilderivater. | |
NO154088C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive tetrahydrokinoliner. |